Skip to main content
. Author manuscript; available in PMC: 2018 Apr 12.
Published in final edited form as: Catheter Cardiovasc Interv. 2015 Apr 24;86(2):E38–E48. doi: 10.1002/ccd.25566

Fig. 2.

Fig. 2

The perfusion defect area was normalized with the baseline AAR, and the decrease in the perfusion defect area from day 2 to day 28 was significantly greater in the single bolus group compared to the placebo group.